667 related articles for article (PubMed ID: 23909256)
1. Interferon-γ release assay for tuberculosis in patients with psoriasis treated with tumour necrosis factor antagonists: in vivo and in vitro analysis.
Sauzullo I; Mengoni F; Marocco R; Potenza C; Skroza N; Tieghi T; Lichtner M; Vullo V; Mastroianni CM
Br J Dermatol; 2013 Nov; 169(5):1133-40. PubMed ID: 23909256
[TBL] [Abstract][Full Text] [Related]
2. Clinical experience of QuantiFERON(®) -TB Gold testing in patients with psoriasis treated with tumour necrosis factor blockers in Taiwan.
Chiu HY; Hsueh PR; Tsai TF
Br J Dermatol; 2011 Mar; 164(3):553-9. PubMed ID: 21083541
[TBL] [Abstract][Full Text] [Related]
3. The effects of rituximab therapy on released interferon-γ levels in the QuantiFERON assay among RA patients with different status of Mycobacterium tuberculosis infection.
Chen YM; Chen HH; Lai KL; Hung WT; Lan JL; Chen DY
Rheumatology (Oxford); 2013 Apr; 52(4):697-704. PubMed ID: 23264552
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers.
Saraceno R; Specchio F; Chiricozzi A; Sarmati L; Amicosante M; Chimenti MS; Chimenti S
Expert Opin Biol Ther; 2014 Feb; 14(2):151-6. PubMed ID: 24303977
[TBL] [Abstract][Full Text] [Related]
5. Latent tuberculosis infection in patients with chronic plaque psoriasis who are candidates for biological therapy.
Gisondi P; Pezzolo E; Lo Cascio G; Girolomoni G
Br J Dermatol; 2014 Oct; 171(4):884-90. PubMed ID: 24863903
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of latent tuberculosis infection before initiation of anti-tumor necrosis factor therapy using both tuberculin skin test and QuantiFERON-TB Gold In Tube assay.
Kim HC; Jo KW; Jung YJ; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Shim TS
Scand J Infect Dis; 2014 Nov; 46(11):763-9. PubMed ID: 25195652
[TBL] [Abstract][Full Text] [Related]
7. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
Sato S; Nagai H
Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
[TBL] [Abstract][Full Text] [Related]
8. Mycobacterial interferon-γ release variations during longterm treatment with tumor necrosis factor blockers: lack of correlation with clinical outcome.
Scrivo R; Sauzullo I; Mengoni F; Priori R; Coppola M; Iaiani G; DI Franco M; Vullo V; Mastroianni CM; Valesini G
J Rheumatol; 2013 Feb; 40(2):157-65. PubMed ID: 23204217
[TBL] [Abstract][Full Text] [Related]
9. Clinical applicability of Quantiferon-TB-Gold testing in psoriasis patients during long-term anti-TNF-alpha treatment: a prospective, observational study.
Garcovich S; Ruggeri A; D'Agostino M; Ardito F; De Simone C; Delogu G; Fadda G
J Eur Acad Dermatol Venereol; 2012 Dec; 26(12):1572-6. PubMed ID: 21923840
[TBL] [Abstract][Full Text] [Related]
10. Detection and management of latent tuberculosis infections before biologic therapy for psoriasis.
Amerio P; Amoruso G; Bardazzi F; Campanati A; Cassano N; Conti A; Gisondi P; Guarneri C; Mazzotta A; Piaserico S; Prestinari F; Prignano F; Zane C; de Simone C
J Dermatolog Treat; 2013 Aug; 24(4):305-11. PubMed ID: 22208431
[TBL] [Abstract][Full Text] [Related]
11. Positive conversion of tuberculin skin test and performance of interferon release assay to detect hidden tuberculosis infection during anti-tumor necrosis factor agent trial.
Park JH; Seo GY; Lee JS; Kim TH; Yoo DH
J Rheumatol; 2009 Oct; 36(10):2158-63. PubMed ID: 19723901
[TBL] [Abstract][Full Text] [Related]
12. Interferon-γ release assay in the diagnosis of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea.
Chang B; Park HY; Jeon K; Ahn JK; Cha HS; Koh EM; Kang ES; Koh WJ
Clin Rheumatol; 2011 Dec; 30(12):1535-41. PubMed ID: 21556777
[TBL] [Abstract][Full Text] [Related]
13. Biphasic emergence of active tuberculosis in rheumatoid arthritis patients receiving TNFα inhibitors: the utility of IFNγ assay.
Chen DY; Shen GH; Chen YM; Chen HH; Hsieh CW; Lan JL
Ann Rheum Dis; 2012 Feb; 71(2):231-7. PubMed ID: 22021896
[TBL] [Abstract][Full Text] [Related]
14. Quantiferon TB Gold and tuberculin skin tests for the detection of latent tuberculosis infection in patients treated with tumour necrosis factor alpha blocking agents.
Klein M; Jarosová K; Forejtová S; Bečvář R; Sedová L; Pavelka K; Simková G; Svobodová R; Hviscová K; Mann H; Půtová I; Vencovský J
Clin Exp Rheumatol; 2013; 31(1):111-7. PubMed ID: 23101473
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the use of the interferon-γ response to Mycobacterium tuberculosis-specific antigens in patients with psoriasis prior to antitumour necrosis factor-α therapy: a prospective head-to-head cross-sectional study.
Martyn-Simmons CL; Mee JB; Kirkham BW; Groves RW; Milburn HJ
Br J Dermatol; 2013 May; 168(5):1012-8. PubMed ID: 23278714
[TBL] [Abstract][Full Text] [Related]
16. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population.
Ponce de Leon D; Acevedo-Vasquez E; Alvizuri S; Gutierrez C; Cucho M; Alfaro J; Perich R; Sanchez-Torres A; Pastor C; Sanchez-Schwartz C; Medina M; Gamboa R; Ugarte M
J Rheumatol; 2008 May; 35(5):776-81. PubMed ID: 18398944
[TBL] [Abstract][Full Text] [Related]
17. Serial QuantiFERON TB-gold in-tube testing during LTBI therapy in candidates for TNFi treatment.
Bartalesi F; Goletti D; Spinicci M; Cavallo A; Attala L; Mencarini J; Fiori G; Li Gobbi F; Mantella A; Benucci M; Prignano F; Pimpinelli N; Matucci Cerinic M; Girardi E; Bartoloni A
J Infect; 2013 Apr; 66(4):346-56. PubMed ID: 23103667
[TBL] [Abstract][Full Text] [Related]
18. How frequently do tuberculosis screening tests convert in inflammatory bowel disease patients on anti-tumour necrosis factor-alpha? A pilot study.
Bermejo F; Algaba A; Chaparro M; Taxonera C; Garrido E; García-Arata I; Guerra I; Gisbert JP; Olivares D; de-la-Poza G; López-Sanromán A
Dig Liver Dis; 2013 Sep; 45(9):733-7. PubMed ID: 23587496
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of the combination of a whole-blood interferon-gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy.
Chen DY; Shen GH; Hsieh TY; Hsieh CW; Lan JL
Arthritis Rheum; 2008 Jun; 59(6):800-6. PubMed ID: 18512714
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists.
Hamdi H; Mariette X; Godot V; Weldingh K; Hamid AM; Prejean MV; Baron G; Lemann M; Puechal X; Breban M; Berenbaum F; Delchier JC; Flipo RM; Dautzenberg B; Salmon D; Humbert M; Emilie D;
Arthritis Res Ther; 2006; 8(4):R114. PubMed ID: 16859506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
